Diseases of Aquatic Organisms Inter-Research
Diseases of Aquatic Organisms

IR Home



DAO
Home
Editors
Forthcoming
Information



Journals
Home
MEPS
AME
CR
DAO
ESEP
Search
Subscribe

Book Series
EE Books
Top Books
Order

Discussion Forums
Home

Research
Endangered Species Programs

Institutions
International Ecology Institute
Eco-Ethics International Union

Foundation
Otto Kinne Foundation

DAO 49:39-44 (2001)

Abstract

Flumequine in Atlantic salmon Salmo salar: disposition in fish held in sea water versus fresh water

Sidsel Sohlberg1,*, Kristian Ingebrigtsen1, Magne K. Hansen1, William L. Hayton2, Tor Einar Horsberg1

1 Department of Pharmacology, Microbiology, and Food Hygiene, The Norwegian School of Veterinary Science, PO Box 8146 Dep., 0033 Oslo, Norway
2 Ohio State University, College of Pharmacy, Columbus, Ohio 43210, USA

*E-mail: sidsel.sohlberg@veths.no

ABSTRACT: 14C-labeled flumequine was administered as a single oral (5 mg kg-1, 86 µCi kg-1) or intravenous (5 mg kg-1, 82 µCi kg-1) dose to Atlantic salmon Salmo salar held in sea water or in fresh water. The absorption, tissue distribution and elimination were determined by means of liquid scintillation counting and whole-body autoradiography. The drug was rapidly absorbed and extensively distributed in all groups of fish. Radiolabeled compound was present in blood and muscle for more than 8 wk in the freshwater groups. In the seawater groups, however, no radioactivity was detected in the blood and muscle after 4 d and 2 wk, respectively. It was concluded that flumequine was eliminated at a substantially higher rate from Atlantic salmon in sea water than in fresh water.

KEY WORDS: Flumequine · Kinetics · Whole-body autoradiography · Atlantic salmon

Full text in pdf format

Published in DAO Vol. 49, No. 1 (2001) on December 20
Print ISSN: 0177-5103; Online ISSN: 1616-1580. Copyright © Inter-Research, Oldendorf/Luhe, 2001

Copyright © 2002; Inter-Research
Webmaster: webmaster@int-res.com